Raelipskie Partnership’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300K | Buy |
12,358
+328
| +3% | +$7.95K | 0.14% | 61 |
|
|
2025
Q1 | $305K | Sell |
12,030
-2,200
| -15% | -$55.7K | 0.16% | 61 |
|
|
2024
Q4 | $378K | Sell |
14,230
-660
| -4% | -$17.5K | 0.19% | 58 |
|
|
2024
Q3 | $431K | Sell |
14,890
-825
| -5% | -$23.9K | 0.21% | 58 |
|
|
2024
Q2 | $440K | Buy |
15,715
+250
| +2% | +$7K | 0.23% | 57 |
|
|
2024
Q1 | $429K | Sell |
15,465
-8,128
| -34% | -$226K | 0.24% | 56 |
|
|
2023
Q4 | $679K | Buy |
+23,593
| New | +$679K | 0.41% | 49 |
|